These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 19820250)

  • 1. Antibiotics for community-acquired pneumonia.
    Dryden M; Hand K; Davey P;
    J Antimicrob Chemother; 2009 Dec; 64(6):1123-5. PubMed ID: 19820250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of CURB65-guided antibiotic therapy in community-acquired pneumonia.
    Chalmers JD; Singanayagam A; Akram AR; Choudhury G; Mandal P; Hill AT
    J Antimicrob Chemother; 2011 Feb; 66(2):416-23. PubMed ID: 21081545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic testing to establish a microbial cause is helpful in the management of community-acquired pneumonia.
    Skerrett SJ
    Semin Respir Infect; 1997 Dec; 12(4):308-21. PubMed ID: 9436958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Short course antibiotherapies in community-acquired pneumonia].
    Bulbul Y; Ozlu T
    Tuberk Toraks; 2008; 56(3):344-52. PubMed ID: 18932039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in antibiotic therapy for community-acquired pneumonia.
    Viasus D; Garcia-Vidal C; Carratalà J
    Curr Opin Pulm Med; 2013 May; 19(3):209-15. PubMed ID: 23422416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience in the management of community-acquired pneumonia: lessons from the use of fluoroquinolones.
    Carratalá J; Martín-Herrero JE; Mykietiuk A; García-Rey C
    Clin Microbiol Infect; 2006 May; 12 Suppl 3():2-11. PubMed ID: 16669924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic therapy of hospitalized patients with community-acquired pneumonia: an international perspective from the CAPO Cohort Study.
    Peyrani P; Christensen D; LaJoie AS; Nakamatsu R; Arnold F; Schulz P; Toala I; Ramirez A; Lobo S; Johnson B; Chesnut D; Richmond B; De La Cruz R; Carrico R; Ramirez J;
    J Ky Med Assoc; 2006 Nov; 104(11):513-7. PubMed ID: 17175853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of pneumonia acquired in the community].
    Waschbisch T; Schlesser M; Nati R
    Bull Soc Sci Med Grand Duche Luxemb; 2002; (2):121-34. PubMed ID: 12664656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Optimizing the antibiotics policy in The Netherlands. VIII. Revised SWAB guidelines for antimicrobial therapy in adults with community-acquired pneumonia].
    Schouten JA; Prins JM; Bonten M; Degener JE; Janknegt R; Hollander JM; Jonkers R; Wijnands W; Verheij T; Sachs A; Kullberg BJ
    Ned Tijdschr Geneeskd; 2005 Nov; 149(45):2495-500. PubMed ID: 16304886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers to the effective management of respiratory tract infections in the community.
    Saginur R
    Infection; 2001 Dec; 29 Suppl 2():3-10. PubMed ID: 11785853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Principles of antibiotic treatment of community-acquired pneumonia in the outpatient setting.
    Segreti J; House HR; Siegel RE
    Am J Med; 2005 Jul; 118 Suppl 7A():21S-28S. PubMed ID: 15993674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy of newer agents in short-duration therapy for community-acquired pneumonia.
    File TM
    Clin Infect Dis; 2004 Sep; 39 Suppl 3():S159-64. PubMed ID: 15546111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibiotherapy for acute CAP in adults].
    Denes E
    Med Mal Infect; 2006; 36(11-12):718-33. PubMed ID: 17092678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guideline tyranny: primum non nocere.
    Baum SG; Kaltsas A
    Clin Infect Dis; 2008 Jun; 46(12):1879-80. PubMed ID: 18462101
    [No Abstract]   [Full Text] [Related]  

  • 15. What new antibiotics to offer in the outpatient setting.
    Fraser KL; Grossman RF
    Semin Respir Infect; 1998 Mar; 13(1):24-35. PubMed ID: 9543473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy.
    Charles PG; Whitby M; Fuller AJ; Stirling R; Wright AA; Korman TM; Holmes PW; Christiansen KJ; Waterer GW; Pierce RJ; Mayall BC; Armstrong JG; Catton MG; Nimmo GR; Johnson B; Hooy M; Grayson ML;
    Clin Infect Dis; 2008 May; 46(10):1513-21. PubMed ID: 18419484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicted effects on antibiotic use following the introduction of British or North American guidelines for community-acquired pneumonia in The Netherlands.
    Oosterheert JJ; Bonten MJ; Schneider MM; Hoepelman IM
    Clin Microbiol Infect; 2005 Dec; 11(12):992-8. PubMed ID: 16307553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current treatment of community-acquired pneumonia.
    Liapikou A; Torres A
    Expert Opin Pharmacother; 2013 Jul; 14(10):1319-32. PubMed ID: 23663104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of aetiological tests for guiding antibiotic therapy in community-acquired pneumonia.
    Strålin K
    Int J Antimicrob Agents; 2008 Jan; 31(1):3-11. PubMed ID: 17920819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of gemifloxacin in community-acquired pneumonia.
    Tillotson GS
    Expert Rev Anti Infect Ther; 2008 Aug; 6(4):405-18. PubMed ID: 18662107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.